A sampling of media coverage that profiles or mentions CCRM

The Power List 2024. The Medicine Maker, April 10, 2024.

Two new gene therapies could present possible cure for sickle cell disease, but access is an obstacle. The Globe and Mail, March 13, 2024.

New cell and gene therapy training laboratory opens at OVC. Ontario Veterinary College, February 21, 2024.

NGen reveals $86.7M in advanced manufacturing projects at the N3 summit. Canadian Manufacturing, February 9, 2024.

Construction of GoCo Active Lab has begun. Nordic Life Science News, January 26, 2024.

Gene therapy revolutionizing hemophilia treatment, unlocking new research opportunities. Healthing, January 25, 2024.

Will AI expertise push Canada forward as a biopharma hub? In Vivo, January 22, 2024. (Subscription required to view this article.)

Life Sciences Ontario announces recipients of 2024 LSO Awards. National Post, January 15, 2024.

BMC names their new Board of Directors. Canadian Manufacturing, January 12, 2024.

Canada’s biomedical brain drain is reversing. Let’s continue that trend. The Hill Times, January 8, 2024.

A sampling of media coverage that profiles or mentions CCRM

Canadian careers in cell and gene. The Medicine Maker, December 28, 2023.

Medicine by Design symposium panel and announcement put a focus on intentional innovation through partnerships. U of T News, December 20, 2023.

Medicine by Design, CCRM launch alliance to bolster Canada’s leading position in regenerative medicine. U of T News, December 11, 2023.

Canadian biomanufacturing: Empowering global innovators in cell and gene therapy. ISCT Telegraft Hub, December 2023.

Multiplex Construction Canada and McMaster Innovation Park celebrate the OmniaBio project delivery. Canadian Manufacturing, November 29, 2023.

New innovation cluster for advanced therapies. Nordic Life Science News, October 8, 2023.

Canada and Sweden partner on sustained engagement on critical raw materials, battery value chains and emerging technologies. Canadian Manufacturing, October 6, 2023.

Creating a global ecosystem. Manufacturing in Focus, September issue, 2023.

Why these B.C. companies are at the forefront of therapeutics. Prince George Citizen, September 21, 2023.

Summer camp for scientists: A 2023 program participant’s reflections on Summer by Design. Stem Cell Network, August 2023.

Commercialising advanced therapies: Industry perspectives. Drug Discovery World, August 4, 2023.

New microcredentials to strengthen the talent pipeline for Canada’s biomanufacturing industry. University of Toronto Engineering News, July 25, 2023.

Michael May on Next Great Big Ideas podcast. NGBIdeas, July 18, 2023.

Summer by Design: 10 highlights from the program. Medicine by Design, July 7, 2023.

Michael May’s reading list reflects his passion for science and technology. Zoomer, July 5, 2023.

Cell and gene therapy: Canada’s chance to be a global leader in life sciences. Maclean’s and Health Insight, June 15, 2023.

Summer by Design to welcome a 2023 cohort from 17 global institutions to U of T to learn about the business of regenerative medicine. U of T News, June 14, 2023.

Vinnova supports formation of Nordic CCRM Hub. Contract Pharma, May 30, 2023.

New Swedish innovation cluster for advanced therapies. Nordic Life Science News, May 24, 2023.

New laboratory for the advanced medicines of the future will strengthen Sweden’s position in global research. GoCo Health Innovation City, May 23, 2023.

CATTI starts up CGT training centre at University of Guelph. BioPharm International, May 17, 2023.

CATTI opens a cell and gene therapy training centre at the University of Guelph. Canadian Manufacturing, May 15, 2023.

CCRM’s blueprint for a sustainable CGT ecosystem in Canada. BIOTECanada Insights, Spring 2023.

Unlocking a cure for heart disease. University Health Network, April 25, 2023.

Nonprofit to Operate Biologics Manufacturing Centre. Mirage News, April 21, 2023.

U of T’s Leah Cowen on Canada’s opportunity to become a genomics “powerhouse.” U of T News, March 15, 2023.

Catamaran Bio, OmniaBio Partner to Advance Allogeneic CAR-NK Cell Therapies. Contract Pharma, March 14, 2023.

U of T home to new hub that will strengthen Canada’s pandemic preparedness and increase biomanufacturing capacity. U of T News, March 2, 2023.

MicrofluidX And CCRM Partner On End-To-End Bioprocessing Of CAR-T Cell Therapies. Cell & Gene, January 11, 2023.

CCRM Partners with Membio for Developing Single-Use Bioreactor to Streamline Viral Vector Production. GEN, January 9, 2023.

CCRM Partners with Membio to Streamline Production of Viral Vectors for Cell and Gene Therapies. Contract Pharma, January 9, 2023.

Innovating in iPSC differentiation & engineering. Cell & Gene Therapy Insights, January 2023.

A sampling of media coverage that profiles or mentions CCRM

OmniaBio: Ready for the Global Biomanufacturing Boom. ISCT Telegraft Hub, November 2022 issue.

Avectas Expands Collaboration with CCRM and OmniaBio Inc. Contract Pharma, November 30, 2022.

Resolution Therapeutics and CCRM Enter Research Collaboration. Contract Pharma, November 11, 2022.

Toronto and Minnesota health ecosystems offer great promise for Finnish companies. Health Capital Helsinki website, November 7, 2022.

Vancouver is ready to foster the next generation of biotech companies. Vancouver Tech Journal, October 27, 2022.

Government Engagement Bodes Well For [Canadian] Life Sciences. Market Screener, October 26, 2022.

Catching up with Hamilton: A city on the move. Real Estate News Exchange, October 24, 2022.

NGen appuie la fabrication commerciale de thérapies cellulaires et géniques au Canada. CScience, October 11, 2022.

Innovation and commercialization in Southern Ontario. Synapse Consortium Brochure, Page 21. October 6, 2022.

Three ways smart site selection is helping life sciences companies turn innovation into commercialization. Investment Monitor, September 23, 2022.

CBRE Helps Launch Game-Changing Biomanufacturing Facility For Hamilton. CBRE website. September 7, 2022.

CCRM, A Premier Incubator of CGT Companies. Life Sciences Review, August 2022 issue.

Biotech boom: 4 ways stem cells are changing how we treat disease. MaRS Discovery District website. July 19, 2022.

CDL’s new global Advanced Therapies stream brings together industry leader CCRM, four top universities on two continents. Financial Post, June 30, 2022.

‘This is the future of medicine’: Centre for Commercialization of Regenerative Medicine CEO Michael May on bringing Canada’s life science discoveries to market. Toronto Star, June 25, 2022.

OmniaBio, Medipost Ink Acquisition and Investment Deal. Contract Pharma, June 7, 2022.

A Special Series Dedicated to Advances in Advanced Medicine. The Medicine Maker, May 27, 2022.

CATTI: Closing Canada’s biomanufacturing skills gap. BIOTECanada Insights, May 24, 2022.

Canada aims to get a slice of the growing global market for cell and gene therapies. Toronto Star, May 18, 2022.

Federal investment required to build a cell and gene therapy ecosystem in Canada, says Innovation Economy Council. Research Money, May 10, 2022.

AcCELLerate-ON awards $900K to four projects that put Canadian cellular agriculture on the map. Food Matters Live, May 6, 2022.

What’s a CDMO and why do biotech startups need them? Let’s ask Canada. Crunchbase News, May 5. 2022.

Healthcare Is a Cost. But It’s Also a Business Opportunity. Canadian Business, April 26, 2022.

Tech update: Using artificial intelligence to solve supply chain snarls, and consolidation in Canadian crypto. The Peterborough Examiner, April 22, 2022.

Canada should be manufacturing its own cell and gene therapies, not just vaccines. The Globe and Mail, April 11, 2022.

Ontario antes up $580M for C&G therapy plant in Hamilton. Endpoints News, April 1, 2022.

Gene therapy manufacturing coming to McMaster Innovation Park. The Bay Observer, April 1, 2022.

Ontario invests in $580 million gene and cell therapy facility in Hamilton. CHCH-TV, March 31, 2022.

New gene- and cell-therapy manufacturing facility to launch in Hamilton with $580-million commitment. The Globe and Mail, March 31, 2022.

WATCH: Ontario economic development minister to make announcement in Hamilton at 1:30 p.m. CHCH-TV, March 31, 2022.

How Sherif Sheta leads IT to keep Canada on life sciences’ cutting edge. CIO, February 24, 2022.

Canada’s Biomanufacturing Workforce. Manufacturing in Focus, February, 2022.

Hamilton needs manufacturing mojo. The Hamilton Spectator, February 13, 2022.

A sampling of media coverage that profiles or mentions CCRM

Cell therapy weekly: CCRM Enterprises launched to invest in regenerative medicine technology. RegMedNet, December 16, 2021.

Medicine by Design symposium panel explores strategies for strengthening Canada’s bioinnovation ecosystem. Medicine by Design website, December 15, 2021.

Promise and Potential: Filling the Gaps in Cell and Gene Therapy. Manufacturing in Focus and Business in Focus Magazines, December 2021.

Collaboration accelerates biomanufacturing capabilities at MIP. Perspective, December 3, 2021.

Exacis Biotherapeutics partners with CCRM. Contract Pharma, October 25, 2021.

Australia’s Regenerative Medicine Sector – A conversation with CCRM Australia CEO Silvio Tiziani. Ausbiotech Vol. 31 No. 2 (October 2021).

Meet the training institute prepping Ontario for the future of biomedical manufacturing: CATTI. Invest Ontario, October 2021.

Building resilient healthcare systems for a post-crisis era. BIOTECanada Insights, September 2021.

Life Sciences in Ontario and Quebec: A Corridor of Collaboration. Invest in Canada, September 2021.

Time to go on the offence with Canada’s bio-manufacturing strategy. The Hill Times, September 13, 2021.

Life Sciences – When an Intellectual Asset Equals Economic Growth. Boardroom, August 31, 2021.

Canada: Canada’s New Biomanufacturing And Life Sciences Investment Strategy. Mondaq, August 28, 2021.

CellCAN and CCRM partner to launch CATTI. Contract Pharma, July 29, 2021.

McMaster Innovation Park Leads the Charge in Commercializing Discoveries through Advanced Biomanufacturing. Innovating Canada, June 15, 2021.

Canada’s health sector is booming. Here are four trends to watch. Toronto Star, June 17, 2021.

Canadians are polite, but we’re still recruiting your talent, America. TechCrunch, June 15, 2021.

Could this be the “holy grail for cell therapy”? Research 2 Reality, June 9, 2021.

Innovative surgery provides relief for patients with chronic pancreatitis. University Health Network, June 9, 2021.

CCRM enters regenerative medicine partnerships. Contract Pharma, June 1, 2021.

CCRM and Amgen partner to advance emerging medical innovations. Contract Pharma, May 3, 2021.

Galera claims positive update in pancreatic cancer but doesn’t report p-values; Amgen launches Canadian fund in tandem with CCRM. Endpoints News, April 29, 2021.

Being bionic: the future of regenerative medicine. Toronto Star, April 13, 2021.

Have you seen Hamilton? Site Selection Magazine, March 2021.

Canada’s biotech and life sciences sector needs an infusion of talent to scale. MaRS, March 30, 2021.

Toronto’s CCRM prepares for next wave of biomanufacturing demand. Toronto Star (print) and Health Insight (digital), March 27, 2021.

‘Industrializing the production of cells’: Another iPSC player joins the quest for off-the-shelf cell therapies. Endpoints News, February 10, 2021.

Biotech company founded by U of T researchers secures US$85 million in financing. University of Toronto News, February 10, 2021.

Vancouver biotech Notch Therapeutics raises US$85-million in venture funding. The Globe and Mail, February 10, 2021.

Allogene partner Notch snags $85M for renewable cell therapies. Fierce Biotech, February 10, 2021.

Pivotal Experiment Fund to accelerate Medicine by Design-funded research toward impact. Medicine by Design News, February 9, 2021.

Discovering the new life sciences district in Hamilton. Perspective, January 21, 2021.

Investors flock to Canadian device maker Sernova hoping to transform how diabetes is treated. The Globe and Mail, January 21, 2021.

A sampling of media coverage that profiles or mentions CCRM

When Trump goes, Canada will need to up its talent game. Toronto Star, December 21, 2020.

Collaboration is key to made-in-Canada healthcare advancements. FedDev Ontario website, Southern Ontario Spotlight, December newsletter, 2020.

Report Finds Growth In Tech Jobs Since February, Canada Still Experiencing Brain Drain. betakit, December 2, 2020.

Harnessing hope through modern medicine. Manufacturing in Focus, December 2020 – January 2021.

Inside Canada’s Premier Life Sciences Mega Hub. Perspective Hamilton, distributed in The Globe and Mail, November 29, 2020.

Biotech campus at McMaster Innovation Park billed as job creator, pandemic fighter. The Hamilton Spectator, November 19, 2020.

CCRM and MIP plan to build a new biomanufacturing campus. Genetic Engineering and Biotechnology News, November 13, 2020.

Toronto accelerator fosters made-in-Canada approach to cell therapy. Canadian Manufacturing, October 23, 2020.

Cell Therapy Scale-Up Strategies For Commercial Success. Biosimilar Development, October 5, 2020.

2021 Advanced Manufacturing Outlook Report; please view Part 1, Part 2 and Part 3. Canadian Manufacturing and PLANT magazines, October 2020.

Canada can become a leader in regenerative medicine. Innovating Canada, September 25, 2020

Robust Process Development For cGMP Manufacturing of Cell Therapies. Cell & Gene, September 24, 2020.

Practical Tips To Develop A Lentivirus Packaging Cell Line. Cell & Gene, September 9, 2020.

Platform Cell and Gene Therapy Media Development. Cell & Gene, September 9, 2020.

Panel of Canadian regenerative medicine leaders tackle translation and commercialization challenges in panel discussion. Medicine by Design website, August 13, 2020.

Critical planning for regenerative medicine therapies needs to happen now to ensure smooth adoption into health system, paper urges. Medicine by Design website, August 13, 2020.

Securing future of regenerative medicine in Victoria [Australia]. The National Tribune, August 10, 2020.

Pluripotent Stem Cell Expansion And Scale-Up. Cell & Gene, August 5, 2020.

Improving Lentiviral Vector Downstream Processing Workflows. Cell & Gene, August 5, 2020.

Notch Therapeutics Appoints David Main as President and CEO to Advance the Company’s Novel Gene-Edited, iPSC-Derived Immune Cell Therapeutics. Canadian Life Sciences Database, July 20, 2020.

U of T spin-off Empirica Therapeutics acquired by U.S. firm. U of T News, July 15, 2020.

Innovation Economy Council: Advanced mfg booming in Ontario. Canadian Manufacturing, July 9, 2020.

Professor’s startup acquired by U.S. firm. Brighter World (McMaster University), June 26, 2020.

Medicine by Design Launches Translation Talks. Medicine by Design website, June 16, 2020.

The New Wave of Innovation. Contract Pharma, June 4, 2020.

The Short Report. Research Money, May 20, 2020.

Report: Startups Could Fuel The Recovery Of Canada’s Economy. BetaKit, April 28, 2020.

Tech startups are the foundation of Canada’s economic revival and will need stimulus to survive. The Globe and Mail, April 28, 2020.

Master iPSC bank to be produced by CCRM and panCELLa. RegMedNet, April 23, 2020.

panCELLa, CCRM collaborate to benefit academia and industry. Contract Pharma, April 21, 2020.

Avectas collaborates with CCRM on cell engineering tech. BioPharma Reporter, March 4, 2020.

Advancing Platelet-Based Therapeutics for Patients. Genetic Engineering & Biotechnology News, February 11, 2020

Reflections On An Unprecedented Decade In The Cell And Gene Therapy Field. Cell & Gene, February 4, 2020

Why stem cells could be the medical innovation of the century. World Economic Forum website, January 16, 2020

CCRM helping to solve the big problems in regenerative medicine. Genetic Engineering & Biotechnology News, January 3, 2020

A sampling of media coverage that profiles or mentions CCRM

Measure Twice, Treat Once: Navigating the Regulatory Landscape of Assay Development to Ensure High-Quality CGT Products. BioProcess International, December 16, 2019.

Medicine by Design draws hundreds to annual research event, praise by federal innovation minister. U of T News, December 9, 2019.

Biotech ecosystems aim to start the talent pipeline early in a student’s career. The Globe and Mail, November 14, 2019.

The Innovations Arms Race: Commercializing Life Sciences in Toronto. Life Sciences Career Development Society website. November 11, 2019.

NGen Manufacturing Program Supports $4.2M Project. Mentor Works, November 6, 2019.

Allogene sets sights on iPS cell-based allogeneic therapies via Notch partnership. BioCentury, November 5, 2019.

Allogene, Notch partner to develop iPSC-derived blood cancer therapies. Genetic Engineering & Biotechnology News, November 5, 2019.

Forward thinking – evolving the cell and gene therapy industry: Modern CAR T-cell process addresses future demand. BioProcess International, October 28, 2019.

Special report on cell biology: Making bioprogress. DDNews, October 5, 2019.

Out of order: Check your ego. DDNews, September 2019.

Ontario continues to establish its role as a world leader in regenerative medicine. Clinical Trials Ontario website, September 12, 2019.

Special report on stem cells: Hope over hype. DDNews, September 10, 2019.

NGen Contributes to C$4.2m Canadian viral vector manufacturing project. Manufacturing Chemist, September 10, 2019.

Advanced Manufacturing Supercluster project kicks off with NGen funding. Canadian Manufacturing, August 22, 2019.

Advanced manufacturing supercluster invests in potentially life-saving gene therapies. U of T News, August 22, 2019.

Ontario’s Advanced Manufacturing Supercluster Announces First Project. BetaKit, August 21, 2019.

Big Red Oak honoured with 2019 video awards. Big Red Oak, August 7, 2019.

Gene-Editing Techniques Target New Applications. BioPharm International, August 1, 2019.

Designing production facilities of the future. BioPharma-Asia, July 30, 2019.

Process development of a closed CAR-T manufacturing process. BioProcess International, July 18, 2019.

These startups want to freeze your cells.  Medium’s Elemental, June 27, 2019.

Innovative Solutions from Industry 4.0. (Webinar) BioPharma-Asia, June, 10, 2019.

CCRM & the new CCVP facility: an interview with Director of Operations, Helen Pejnovich, P.Eng. Society Notes, June 5, 2019.

Ontario companies fill marketplace voids. Biotechnology Focus, June 3, 2019.

Cell Therapy Manufacturing Under GMP – How And When To Get Started. Cell & Gene, May 2, 2019.

Are we moving towards a more automated CAR-T cell manufacturing process? RegMedNet, April 30, 2019.

Collaboration will drive regenerative medicine: Toronto development center will help to advance the field. BioProcess International, April 18, 2019.

Study reveals large molecular differences between stem cells grown on different biomaterials. Donnelly Centre website. April 15, 2019.

Michael May discusses the intersection of medical devices in regenerative medicine. StarFish Medical, Mar. 20, 2019.

GE Healthcare looks to spawn growth in regenerative medicine with CCRM partnership. Genetic Engineering & Biotechnology News, Jan. 31, 2019.

Federal government to defund Networks of Centres of Excellence. The Varsity, Jan. 29, 2019.

General Electric: The immunotherapy hurdle – and why doctors could soon predict how each patient will respond. Market Screener, Jan. 6, 2019.

Navigating the regulatory complexity of Regenerative Medicine in Canada. Biotechnology Focus, December 2018/January 2019 issue.

A sampling of media coverage that profiles or mentions CCRM

MaRS: Innovate inclusively. Compete fiercely. MaRS Magazine, December 11, 2018.

De-mystifying and de-risking process development through early engagement with a CDMO. Cell & Gene, Nov. 27, 2018.

Tackling the talent gap in the cell and gene therapy industry. Signals and Biotechnology Focus, Nov. 10, 2018.

Get ready…get set…GMP and cell therapy. Genetic Engineering and Biotechnology News, Nov. 6, 2018.

New art and science exhibit at Pearson Airport. “Metro Morning with Matt Galloway,” CBC Radio, October 10, 2018.

Nontraditional pharma companies. PharmaVOICE.com, October 2018.

Artful Science exhibit takes off at Toronto Pearson Airport. The Varsity, September 30, 2018.

‘Summer camp for researchers’ aims to accelerate regenerative medicine discoveries into new therapies. U of T News, September 26, 2018.

A call for unity at TERMIS 2018. BMC Series Blog, September 24, 2018.

Take a high-flying trip to the heart of discovery. Research2Reality, September 21, 2018.

CCRM liaises to advance regenerative medicine internationally in Japan. Biotechnology Focus, September 7, 2018.

Canadian technology and innovation: making strides in the global cell therapy landscape. Biotechnology Focus, August 16, 2018.

Injectable Discogenic Cell Therapy Developed to Alleviate Back Pain. Technology Networks, August 6, 2018.

Federal government renews $15 million in funding for Toronto’s regenerative medicine cluster. U of T News, July 30, 2018.

The Government of Canada makes substantial investment of nearly $80-million. Biotechnology Focus, July 30, 2018.

Closed system cell therapy manufacturing – Moving from the lab to clinical and commercial production (podcast). The Cell Culture Dish, July 26, 2018.

Toronto added more tech jobs last year than Silicon Valley – or anywhere else in North America: Report. U of T News, July 26, 2018.

Supporting the Development of Regenerative Medicines. Technology Networks, July 6, 2018.

CCRM: Cultivating good health one stem cell treatment at a time. Society Notes – The official blog of the Ontario Society of Professional Engineers, June 27, 2018.

Medicine by Design researchers clear hurdles toward robust supply of stem cells for research and therapy. Medicine by Design website, June 6, 2018.

GE and CCRM partner with DiscGenics on new cell therapy. BioPharm International, May 31, 2018.

Navigating immunotherapies to Canada. Biotechnology Focus, May 18, 2018.

OSPE Supports Remarkable. Society Notes – The official blog of the Ontario Society of Professional Engineers, May 9, 2018.

A Cure for Investor Skepticism (article and video). Research2Reality, May 8, 2018.

Fixing the weak links in the cell therapy manufacturing chain: processes, people and partnerships. Cell and Gene Therapy Insights, April 25, 2018.

Hope beyond hype: The pursuit of longevity in stem cell therapies. Biotechnology Focus, April 27, 2018.

U of T conference explores the future of health care – and how Toronto will shape it. U of T News, April 13, 2018.

In Cold Blood: These Scientists Are Using Very, Very Cool Science To Fight Cancer. GE Reports, April 11, 2018.

A conversation with Peter Zandstra, PhD, FRSC(E). BCRedMed, April 10, 2018.

Fulfilling the Promise of Much-Needed Cures (article and video). Research2Reality, April 10, 2018.

Cell therapy production moves to factory floor. Genetic Engineering and Biotechnology News, March 15, 2018.

Toronto’s Centre for Advanced Therapeutic Cell Technologies Makes Its Mark on Regenerative Medicine. Lab Manager, March 8, 2018.

Industrial medicine: Cell therapy scales up. GE Reports, March 5, 2018.

Canadian biomedical engineers are bringing new advanced therapeutic products to Canadians. Biotechnology Focus, February 27, 2018.

Canada Eyes Leading Role in Regenerative Medicine (article and video). Research2Reality, February 20, 2018.

From stem cells to revenue: Bringing regenerative medicine to the masses. Financial Post, January 24, 2018.

Support of GE Healthcare to quicken CBMG’s cell therapy manufacturing. Pharmacy Choice, January 23, 2018.

Manufacturing medical marvels: How a new cell therapy platform helps scale up manufacturing to reach more patients. The Pulse, January 19, 2018.

Stem Cell Manufacturing: It’s All about Scale. Genetic Engineering and Biotechnology News, January 1, 2018.

A sampling of media coverage that profiles or mentions CCRM

Repurposed drug could open door to more stem cell transplants. Technology Networks, December 21, 2017.

A repurposed drug could be the key to successful stem cell transplants. Biotechnology Focus, December 20, 2017.

Medicine by Design researchers seek to make blood stem cell transplants available to more patients. MbD, University of Toronto website. December 15, 2017.

Stem Cells Meet AI in Quest to Mass-Produce Key Disease Fighters. Bloomberg, December 12, 2017.

The real health benefits of avocado. Chatelaine, November 30, 2017.

U of T Engineering celebrates industry collaborations and honours key partners. University of Toronto website, November 27, 2017.

Survivor: This woman’s battle with leukemia is pointing the way to the future of healthcare. GE Reports, November 22, 2017.

Japan faces new competition in the race for ‘regenerative medicine’. Nikkei Asian Review, November 8, 2017.

Canada Joins the CAR T-Cell Club. Alliance of Advanced BioMedical Engineering website. November 6, 2017.

New centre is tackling manufacturing challenge of cell therapy field. World Pharma Today, October 31, 2017.

The fast track for regenerative medicine. Biotechnology Focus, October 24, 2017.

Toronto makes pitch to be world’s ‘Stem Cell City’ with new, state-of-the-art lab. U of T News, October 12, 2017.

Race to Market: Collaborating to Accelerate Cell Therapy. The Pulse, October 12, 2017.

Blog: Finding Inspiration at Home and Abroad. MTPConnect website, October 9, 2017.

CCRM and Affigen Partner to Develop Personalized Therapeutics for B-Cell Lymphoma, Leukemia. Lymphoma News Today, October 6, 2017.

When science meets innovation: cell therapies. Hudson Institute of Medical Research, October 4, 2017.

New Center Helps Scientists Reprogram The Immune System To Kill Cancer. GE Reports, September 28, 2017.

BlueRock Therapeutics: A regenerative medicine game-changer. The Ontario Investment Office website, August 29, 2017.

BlueRock Therapeutics opens R&D and manufacturing hub in Toronto. Betakit.com, August 17, 2017.

Michael May of CCRM talks about how to make the perfect pitch [podcast]. Biotechnology Focus, July 25, 2017.

U of T’s Creative Destruction Lab expands, focusing on regenerative medicine. U of T News, July 20, 2017.

Summer by Design draws emerging regenerative medicine leaders from around the world to U of T. Medicine by Design, University of Toronto website, July 16, 2017.

CCRM hosts BRM 2017, promotes innovation in regenerative medicine. Biotechnology Focus, July 14, 2017.

Stem cell conference at U of T to focus on entrepreneurship. U of T News, July 11, 2017.

Spotlight: Ontario’s Regenerative Medicine Pipeline. Biotechnology Focus, June 30, 2017.

Tissue engineering pioneer Michael Sefton to lead Medicine by Design as Executive Director. University of Toronto Faculty of Medicine News, June 28, 2017.

CRISPR: Emerging applications for genome editing technology. Technology Networks, June 26, 2017.

Forging Partnerships In Regenerative Medicine Helps Make Canada A World Leader. National Post – Media Planet, June 22, 2017.

The big guys are here to stay. Biotechnology Focus, June 20, 2017.

What is BlueRock working on? Biotechnology Focus, June 15, 2017.

Top 10 Stem Cell Companies on the NASDAQ. INN Daily, June 14, 2017.

U of T research helps pave the way for an off-the-shelf supply of cells for immunotherapy. Medicine by Design, University of Toronto website, May 25, 2017.

OIRM 2016 Annual Report. OIRM website, May 25, 2017.

BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial. Pharmaceutical-technology.com, May 22, 2017.

Streamlining Stem Cell Manufacturing. GEN, April 24, 2017.

$225M BlueRock Therapeutics “monster” a magnet for Canada’s biotech sector. Financial Post, April 10, 2017.

BlueRock Therapeutics: Ontario’s home-grown stem cell contended. Pharmaceutical Technology, March 13, 2017.

Canada shoots for tech boost as Trump shuts doors. The Times of Israel, March 12, 2017.

BrainStorm seeks early Health Canada nod for NurOwn treatment. Drug Delivery Business News, February 22, 2017.

Observers urge care in earmarking funds for innovation clusters. The Hill Times, February 8, 2017.

CCRM: Cultivating a culture of cooperation to advance the global regenerative medicine industry. RegMedNet, February 2, 2017.

Collaboration brings together MBA and PhD students to map regenerative medicine ecosystem. Medicine by Design, University of Toronto website. February 2, 2017.

Une exposition sur les cellules souches au Musee du Fjord. Le Courrier de Saguenay, January 15, 2017.

A sampling of media coverage that profiles or mentions CCRM

Multitiered approach to stem cell discoveries. MaRS Magazine, November 2016.

Molly Shoichet awarded 2016 Till & McCulloch Award. U of T News, October 6, 2016.

Peter Zandstra receives international recognition for outstanding contributions to the development and commercialization of stem cell-based therapies. IBBME, University of Toronto, October 3, 2016.

Canada: A legal market facing up to new challenges. Leaders League, September 26, 2016.

Special op/ed: Canada can lead the world in regenerative medicine – but it won’t happen without strategic investment. Signals, August 30, 2016.

The Future is STEM. STEM Magazine, August 2016 issue.

Doctors’ Notes: Why scientific breakthroughs take time to move from lab to bedside. The Toronto Star, August 8, 2016.

Visualizing the cell and gene therapy supply chain of the future, an interview with Phil Vanek. (Video) Cell & Gene Therapy Insights, summer 2016.

The C Word. Bio Business, July/August 2016 issue.

Preparing for a cell culturing industry. Pharmaceutical Commerce, July 19, 2016.

There isn’t A cure for cancer. There are 7.4 billion.* The Pulse, July 13, 2016.

Women in cell & gene therapy. Phacilitate, June 23, 2016.

The BridGE@CCRM: Where cell and gene therapies go mainstream. Biotechnology Focus, June 7, 2016.

The Pace of Progress in Heart Regeneration. Biotechnology Focus, June 6, 2016

Peter Zandstra named University Professor, U of T’s highest academic rank. U of T Engineering News, June 3, 2016.

MaRS Innovation & CCRM strike deals in Israel. Biotechnology Focus PODCAST, May 31, 2016.

Times Are Exponentially A-Changin’ – And You Haven’t Seen Anything Yet, Says The X Prize’s Peter Diamandis. GE Reports, May 17, 2016.

Taking the ‘wrinkles’ out of drug development. University of Toronto (Faculty of Dentistry), May 17, 2016.

Life Sciences Grows Up. Lexpert, May 9, 2016.

Mobility After Paralysis? Stem Cells Face Clinical Trials. Research2Reality.com, May 5, 2016.

Toronto, Canada, is the Site of New Centre for Advanced Therapeutic Cell Technologies. ISCT Telegraft, April 2016.

Corporate Partnerships On The Rise: The Toronto Opportunity. Life Science Nation, April 21, 2016.

Cutting-edge clinical trials in stem cell and regenerative medicine. Clinical Trials Ontario, April 20, 2016.

Collaboration will drive regenerative medicine: Toronto development center will help to advance the field. BioProcess International, April 18, 2016.

An engineering road map for scaling up production of stem cell-derived treatments. U of T Engineering News, April 7, 2016.

Canadian federal budget 2016: Research & innovation investment summary. Biotechnology Focus,March 23, 2016.

StemCellTalks inspires Toronto high school students with the promise of regenerative medicine. IBBME at U of T, March 14, 2016.

What does retirement mean when aging may soon be a thing of the past? Entrepreneur, Yahoo Finance,February 29, 2016.

Q&A with Michael May: New cell manufacturing centre will clear bottlenecks, attract clinical trials. Canadian Stem Cell Foundation, Feb. 25, 2016.

New Canadian biotech aims for a novel approach to blood cancer, rare disease. FierceBiotech,February 19, 2016.

Electrical imaging tells tales of the broken heart – and if a stem cell patch can fix it. Expression,February 11, 2016.

Canada Next: MaRS CEO on the future for startups. U of T News, February 2, 2016.

Canada’s stem cell research needs ‘big investment’ to move forward, experts say. CBC.ca, January 31, 2016.

Huge Opportunity For Gene Therapy Research At AnC Bio, Scientists Say. The Orleans Record, Jan. 30 and 31, 2016.

New centre, investment bolsters Ontario’s strength in stem cell technologies and regenerative medicine. Invest in Ontario, January 28, 2016.

Sernova Teams Up with CCRM. Contract Pharma, January 27, 2016.

MaRS Announcement, enGene Partnership, and McMaster Discoveries – EP 5. Biotechnology Focus (Podcast), January 19, 2016.

Canada Opening “International Hub For Stem Cell Therapy.” Futurism, January 18, 2016.

Trudeau announces $20-million in funding for Toronto stem cell research. Globe and Mail, January 13, 2016.

​Trudeau tours lab ahead of funding announcement (Video). CP24, January 13, 2016.

Prime Minister Justin Trudeau backs commercialization of stem cell research by U of T and partners. U of T News, January 13, 2016.

Ottawa to invest $20M in stem cell research. CTV News, January 13, 2016.

A sampling of media coverage that profiles or mentions CCRM

Gene Therapy to Treat HIV in Clinical Trial. Forbes, December 31, 2015

From Bench to Business. Canadian Journal of Medical Laboratory Science,Winter 2015. 

Stem cells: latest development and potential therapeutics. Biotechin.Asia,December 15, 2015. 

Third Annual 24 Hours of Stem Cells Virtual Conference. The Cell Culture Dish,December 10, 2015. 

Body parts to go. Examiner.com,December 2, 2015.

Banking on cord blood. Biotechnology Focus, November 20, 2015.

Canadian researchers recognized for diabetes breakthrough using stem cells. Forbes,November 20, 2015.

Highlights from #TMM2015. McMaster University’s Stem Cell and Cancer Research Institute blog,November 13, 2015. 

Stem cell exhibit for kids is a hit with adults too. U of T News, November 10, 2015.

Regenerative medicine conference puts spotlight on Toronto. U of T News, October 30, 2015.

Where to Get Your Morning Stem Cell News? Top 15 Accounts to Follow on Twitter. BioInformant, October 28, 2015.

Canada’s emerging cell therapy biotech industry. Financial Post, October 27, 2015.

Canada’s regenerative medicine conference opens in Toronto. Biotechnology Focus, October 26, 2015.

Super Cells: The Power of stem cells exhibit for children at MaRS #Toronto. Teddy Out-Ready (parenting blog), October 21, 2015.

“Think Beyond a Single Batch” says Nick Timmins of CCRM. Future of Biopharma blog, October 21, 2015.

Timothy Kieffer to receive 2015 Till & McCulloch Award: Landmark Canadian paper advances knowledge to cure diabetes. Biotechnology Focus, October 16, 2015.

Analysis…Investing in the future [OIRM’s Dr. Janet Rossant on new $25M funding for stem cell research]. Pan European Networks: Science & Technology, Issue 16, October 12, 2015.

Equipment and resources are the key Bottlenecks in cell therapy commercialization. Future of Biopharma blog, October 2, 2015.

#TMM2015. McMaster University’s Stem Cell and Cancer Research Institute blog, October 2, 2015.

U of T research facilities to expand in new partnership. Lab Product News, September 15, 2015.

U of T Expands Research Facilities in New Partnership with MaRS. U of T News, September 2, 2015

Returning to Form: New funding gives hope for 10 new therapies over the next 10 years. Bio Business,Sept./Oct. 2015.

$1.5B research fund announces first successful funding recipients. Lab Product News, August 12, 2015.

Q&A: Paul Spagnuolo, Cancer and Avocados. Laboratory Equipment, July 30, 2015.

CCRM takes on commercialization role with “Medicine by Design” initiative. Biotechnology Focus, July 30, 2015.

Researchers hope $114-million grant will make Toronto a hub for stem cell research​. The Globe and Mail, July 28, 2015. 

Behind the scenes of Medicine by Design with Molly Shoichet [CCRM advisor] and Peter Zandstra [Chief Scientific Officer]. U of T Engineering News, July 28, 2015.

Banking on cord blood. Ontario Institute for Regenerative Medicine, summer 2015.

Venture capital investors are flocking to burgeoning biotech startups. Financial Post, June 24, 2015. 

Gregory Bonfiglio, Proteus Venture – Investing exclusively in Regenerative Medicine. PharmaTelevision, June 22, 2015.

Quebec: ExCellThera Veut Transformer la Greffe de Cellules Souches. BiotechFinances,22 juin 2015 N-686

Ontario invests $25 million in stem cell research. Biotechnology Focus, June 22, 2015.

Ontario’s biotechs in good company with CCRM’s industry consortium. Ontario Institute for Regenerative Medicine, summer 2015. 

Avocados could hold the key to helping beat rare form of leukemia. The Independent, June 16, 2015.

IRICoR and CCRM partner to launch ExCellThera. Biotechnology Focus, June 15, 2015.

A perfect storm in regenerative medicine. Biotechnology Focus, June 3, 2015.

A collaborative approach to advance stem cell research and commercialization. Ontario Institute for Regenerative Medicine, summer 2015.

New Investment Funds and Network to Accelerate RM Commercialization. BioteCanada: insights Magazine,Spring 2015.

How to Grow a Regenerative Medicine Industry in Canada: Michael May of CCRM. The Life Sciences Report,April 23, 2015.

Stem Cell Research Promises Health and Economic Benefits. Media Planet/National Post,March 21, 2015. 

Commercialized cell therapies goal of regenerative medicine alliance. Lab Product News,March 20, 2015. 

Seeking to cure the incurable: Canada and Japan setting the world pace for innovations in RM. Financial Post,March 10, 2015. 

Newcastle Hosts Major Interactive Science Exhibit Exploring the Wonder of Stem Cells. Pharmiweb.com,March 6, 2015. 

A Recipe for Life Sciences Commercialization. Life Science Leader, February 26, 2015. 

How Canada can capitalize on its stem cell technology advantage. Policy Options, February 18, 2015.